DPP4 and diabetes mellitus: We executed computational methods including 3D QSAR pharmacophore modeling, molecular docking, virtual screening, de novo Evolution and multiconformational docking with the aim of finding the novel, selective and potent DPP-IV inhibitor for the treatment of diabetes.